Log in to save to my catalogue

Intranasal Calcitonin in the Treatment of Acute Charcot Neuroosteoarthropathy: A randomized controll...

Intranasal Calcitonin in the Treatment of Acute Charcot Neuroosteoarthropathy: A randomized controll...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68012134

Intranasal Calcitonin in the Treatment of Acute Charcot Neuroosteoarthropathy: A randomized controlled trial

About this item

Full title

Intranasal Calcitonin in the Treatment of Acute Charcot Neuroosteoarthropathy: A randomized controlled trial

Publisher

Alexandria, VA: American Diabetes Association

Journal title

Diabetes care, 2006-06, Vol.29 (6), p.1392-1394

Language

English

Formats

Publication information

Publisher

Alexandria, VA: American Diabetes Association

More information

Scope and Contents

Contents

Acute CNO was defined by clinical signs: warm, swollen foot and skin temperatures ≥2°C at the site of maximum deformity of the affected foot compared with a similar site on the contralateral foot (infrared thermometer) and confirmed by plain X-ray and three-phase technetium bone scan (9). In conclusion, this study suggests that intranasal calcitoni...

Alternative Titles

Full title

Intranasal Calcitonin in the Treatment of Acute Charcot Neuroosteoarthropathy: A randomized controlled trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_68012134

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68012134

Other Identifiers

ISSN

0149-5992

E-ISSN

1935-5548

DOI

10.2337/dc06-0376

How to access this item